Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by RealScientiston Jan 15, 2018 12:07am
214 Views
Post# 27356219

RE:What was the story with VANC in 2015?

RE:What was the story with VANC in 2015?I posted this a while ago when it started to move. Little bit of history. 

This stock once had hope, then management started to get selfish. Arun was a disaster and absolutely destroyed any shareholder value. Silence from management for months and months. Bad news release after bad news release. This led to a price decrease in the stock from $0.50+ down to $0.08. It was at ~$0.27 when a reverse split was announced, and when it finally happened, the stock price had lost 80% of its value. The down trend continued to $0.15 where quite a few PPs were offered. There are a lot of people who were left major bag holders from its previous highs.


Now Bob Rai has returned some interest here. He managed to bring in EHT, which has created interest from the hot pot sector. The Healthtab by itself is a disaster - guess who owned Healthtab prior to Vanc purchasing rights to it? For those who actually want to do some DD, look at the news releases since Q2/Q3 releases last year. Also, I can't remember who the stock promoter guy was (Jason Donville?), he hyped Vanc to his followers, and after a disappointing Q2/Q3 and silence from management, he told his followers to dump any Vanc stock, which caused a big dip. Arun failed to address the poor numbers and his company being called out. Bob Rai was there for all of this. Now he's in control.

If they can somehow tie marijuana into this company, we might be back on track. I'm encouraged by the current interest, but there needs to be a nice news release for any of this to stick and take this stock for a run. EHT bought in for a reason - we'll just have to wait and see whether that is revealed in a timely manner or if it's nothing to get excited over. 
Read more at https://www.stockhouse.com/companies/bullboard/v.nph/vanc-pharmaceuticals-inc?postid=27106524#3bKI346M7pdWeT4x.99
Bullboard Posts